Bitcoin (BTC) $91,606 reaches a buying level of $62,800 while altcoins continue their day with a 2% loss. As we approach the end of September, significant developments in the coming week may lead to substantial increases in cryptocurrencies in the final quarter. Whether history will repeat itself remains uncertain, but let’s take a look at the current forecasts for DOGE, XRP, and BONK Coin.
XRP Coin News Analysis
The circulating supply of XRP Coin has reached 100 billion, necessitating increased demand to reach a market value of $3-4. For the price to exceed $3 and reach previous highs, the market cap would need to hit $300 billion with this supply. While predicting the future is complex, if the SEC does not appeal the court decision by October 7, XRP may experience short- and mid-term recovery.
Ripple $0.714166 has largely won the ongoing battle, with prices currently above $0.59. Bulls aim to maintain support at $0.59, targeting new highs between $0.73 and $0.94 in a bullish scenario. In a bearish market, current support levels are at $0.58 and the $0.48 – $0.50 range.
BONK Coin Insights
SOL ETF applications could have brought good days, but excitement in the Solana $216 network has faded. Even if BONK Coin is forgotten in the market, it remains a significant asset in its history. When SOL Coin dropped to around $8, BONK emerged to heal the ecosystem’s wounds, distributing airdrops to SOL Coin investors through partnerships with various protocols. Those who could hold until year-end saw substantial gains, though many sold for small profits.
Currently, BONK is trading below the support level of $0.00002179, maintaining around $0.00001561. If it can regain the parallel channel support, it could climb back up to $0.00002917.
Dogecoin (DOGE) Evaluation
As the largest meme coin by market cap, Elon Musk‘s loss of support has negatively impacted DOGE. Nevertheless, it is fighting to reclaim the $0.11 level. Bulls maintaining support at $0.105 have faced challenges in their recent attempts. If selling persists, $0.098 may be tested again; however, with no major negative developments expected soon, there is potential for testing $0.14.